Skip to content

WAUTEAR trial

Phase III study of waterjet versus ultrasonic device in transection efficacy during anatomical liver resection - WAUTEAR trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs052220071
Enrollment
250
Registered
2022-08-09
Start date
2022-08-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver disease, or a healthy donor for living-donor liver transplantation.

Interventions

After obtaining written consent, eligible participants are registered. Using EDC system, participants are randomly assigned to "waterjet device group" or "ultrasonic device group". Liver resection is

Sponsors

Kawai Manabu
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Age 20 years or older. (2) ECOG Performance Status 0 to 2. (3) Written consent provided. (4) Scheduled to undergo (open/laparoscopic) liver resection due to liver disease, or to undergo liver resection as a donor for living-donor liver transplantation. (5) Scheduled to undergo the following surgical procedures: right lobectomy, left lobectomy, right posterior sectionectomy, segment VII segmentectomy (for patients with liver disease) and right lobectomy, left lobectomy (for donors)

Exclusion criteria

Exclusion criteria: (1) Venous tumor thrombus (Vv2, 3). (2) Biliary tumor thrombus (B3, 4). (3) Needing biliary or vascular reconstruction. (4) Dissection area overlaps with area of previous partial hepatectomy. (5) Difficulty in taping hepatoduodenal ligament. (6) Requiring resection of other organs except for gallbladder. (7) BMI of 30 or more. (8) Child-Pugh grade B or C. (9) Platelet count 1.5 mg/dL). (13) Severe respiratory dysfunction (forced expiratory volume in 1 second <1L or requiring rest because of shortness of breath during 100m or several minutes' walking). (14) Other non-appropriate conditions, as determined by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Blood loss during liver resection

Secondary

MeasureTime frame
(1) Total blood loss amount during surgery. (2) Blood loss amount per resected area during liver parenchymal resection. (3) Total operating time. (4) Operating time during liver parenchymal resection. (5) Transection speed. (6) Incidence of blood transfusion. (7) Incidence of postoperative complications. (8) Perioperative mortality. (9) Postoperative days in hospital.

Contacts

Public ContactMasaki Ueno

Wakayama Medical University Hospital

wautear@wakayama-med.ac.jp+81-73-441-0613

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026